SUBSCRIBE
SUBSCRIBE
News   Policy

US FDA Warns Teva Pharmaceutical Industries Limited on California Plant Problems

April 28, 2010 | 
1 min read

Reuters -- U.S. regulators have warned Teva Pharmaceutical Industries about manufacturing violations at a California plant, according to a letter released on Tuesday.

Regulatory
MORE ON THIS TOPIC
Pictured: A scientist works behind an FDA sign/Tay
FDA Tracker
Shorla, Protega Win Expanded Nods for Cancer/Autoimmune, Pain Therapies
October 29, 2024
 · 
195 min read
 · 
Heather McKenzie
FDA signage at its headquarters in Maryland
Approvals
Iterum Wins FDA Approval For Oral UTI Antibiotic, Seeks ‘Strategic Transaction’ for Asset
October 28, 2024
 · 
2 min read
 · 
Tristan Manalac
Exterior view of the headquarters of the Centers for Disease Control and Prevention in Atlanta, Georgia
Vaccines
CDC Reaffirm RSV Vaccination Guidelines, Declines Expanding Coverage to Younger Adults
October 25, 2024
 · 
2 min read
 · 
Tristan Manalac
Novo Nordisk advertising flags and logo on facade
Editorial
Why It’s OK to Talk About Catalent’s Pending Buyout by ‘Novo’
October 24, 2024
 · 
6 min read
 · 
Jef Akst